One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Access
PDF Availablehttps://doi.org/10.1016/s1556-0864(21)01986-9
Copy DOI
Export
Save
Share
Cite Journal: Journal of Thoracic Oncology |  Publication Date: Mar 27, 2021 |
Affiliation: Pius Hospital Oldenburg, Samsung Medical Center, Taipei Veterans General Hospital, University of California, Davis, University of Sydney, Princess Margaret Cancer Centre, University of Chieti-Pescara, University College London, Adelphi Group (United Kingdom), AstraZeneca (United States), AstraZeneca (United Kingdom), Saint Luke's Hospital
144P Delays in epidermal growth factor receptor mutation (EGFRm) testing in advanced (stage IIIb/ IIIc/ IV) non-small cell lung cancer (NSCLC) patients and their impact on the use of first line tyrosine kinase inhibitor (TKIs) in a real-world setting
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
